Lutetium Lu-177 Vipivotide Tetraxetan vs Rituximab

## Lutetium Lu-177 Vipivotide Tetraxetan vs Rituximab: Overview

This comparison examines the pharmacological differences between **Lutetium Lu-177 Vipivotide Tetraxetan** and **Rituximab**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Lutetium Lu-177 Vipivotide Tetraxetan — N/A; Rituximab — 22 days.

## Chemical Properties

**Type**: Lutetium Lu-177 Vipivotide Tetraxetan — Protein; Rituximab — Antibody.